APA (7th ed.) Citation

Cho, C., Byeon, J., Kang, P., Park, H., Ko, E., Mu, C. Y., . . . Lee, Y. J. (2023). Effects of CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy subjects. Archives of pharmacal research, 46(2), 111-116. https://doi.org/10.1007/s12272-022-01423-0

Chicago Style (17th ed.) Citation

Cho, Chang‑Keun, Ji-Young Byeon, Pureum Kang, Hye-Jung Park, Eunvin Ko, Chou Yen Mu, Choon-Gon Jang, Seok-Yong Lee, and Yun Jeong Lee. "Effects of CYP2C19 Genetic Polymorphism on the Pharmacokinetics of Tolperisone in Healthy Subjects." Archives of Pharmacal Research 46, no. 2 (2023): 111-116. https://doi.org/10.1007/s12272-022-01423-0.

MLA (9th ed.) Citation

Cho, Chang‑Keun, et al. "Effects of CYP2C19 Genetic Polymorphism on the Pharmacokinetics of Tolperisone in Healthy Subjects." Archives of Pharmacal Research, vol. 46, no. 2, 2023, pp. 111-116, https://doi.org/10.1007/s12272-022-01423-0.